Inovio Pharmaceuticals Inc


Inovio To Start Phase 2/3 Study Of Covid-19 Candidate In Sept.; Shares Drop 8%

Inovio Pharmaceuticals Inc. plans to initiate Phase 2/3 study trials of INO-4800, its experimental vaccine candidate against the novel coronavirus, in September and …

Wednesday’s Market Insights: DryShips Inc. (DRYS), xG Technology Inc (XGTI), Inovio Pharmaceuticals Inc (INO)

DryShips Inc. (NASDAQ:DRYS) shares fell hard this morning after management announced that a reverse stock split is in the cards.

Analysts Boost Price Targets on Inovio Pharmaceuticals Inc (INO) Following Positive Data for HIV Vaccine

On Wednesday, Inovio Pharmaceuticals Inc (NASDAQ:INO) announced that its HIV vaccine, PENNVAX-GP, had produced an antibody (humoral) immune response as well as a T cell …

Inovio Pharmaceuticals Inc (INO) Moves a Step Closer to an HIV Vaccine; Maxim Lifts Price Target

Inovio Pharmaceuticals Inc (NASDAQ:INO) rose over 20% in Wednesday’s trading session, after the drug maker said its HIV vaccine Pennvax-GP achieved some of …

Here’s Why Inovio Pharmaceuticals Inc (INO) Shares Skyrocket Today

It’s a very rewarding trading day for investors in Inovio Pharmaceuticals Inc (NASDAQ:INO) with shares up over 35%, making the stock Wall Street’s …

Maxim Weighs In on Inovio Pharmaceuticals Inc (INO) Following Positive Clinical Data for MERS and ZIKA Vaccines

Maxim analyst Jason McCarthy reiterated a Hold rating on shares of Inovio Pharmaceuticals Inc (NASDAQ:INO), after the vaccine maker presented positive clinical data for DNA-based …

Stock Update (NASDAQ:INO): Inovio Pharmaceuticals Inc Presented New Positive Clinical Data in Emerging Infectious Diseases

Inovio Pharmaceuticals Inc (NASDAQ:INO) presented positive clinical data on Inovio’s DNA-based vaccines against MERS (Middle East Respiratory Syndrome) (GLS-5300) and Zika (GLS-5700) at …

Stock Update (NASDAQ:INO): Inovio Pharmaceuticals Inc and ApolloBio to Collaborate on Development and Commercialization of VGX-3100 in Greater China

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced that it has entered into a collaboration and license agreement providing ApolloBio Corporation (NEEQ:430187) with the exclusive right …

Stock Update (NASDAQ:INO): Inovio Pharmaceuticals Inc Zika Vaccine Generates Robust Immune Responses in First Human Study; Shares Rise 5%

Inovio Pharmaceuticals Inc (NASDAQ:INO) announced its DNA-based Zika vaccine (GLS-5700) generated robust antigen-specific antibody responses in a first-in-man, multi-center phase I trial. In …

H.C. Wainwright Cuts Price Target For Inovio Pharmaceuticals Inc (INO), But Remains Bullish

Inovio Pharmaceuticals Inc (NASDAQ:INO) released third-quarter financial earnings and a clinical progress update on the firm’s pipeline on Wednesday, November 9th. H.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts